Paper29675397
Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator.
Azria D and 3 others. Front Oncol, 2018. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator. Papers, record 29675397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29675397
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22019144 | Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. | Lancet | 2011 | https://conductscience.org/library/papers/22019144 | PubMed |
| 2 | 27586010 | In vitro cellular radiosensitivity in relationship to late normal tissue reactions in breast cancer patients: a multi-endpoint case-control study. | Int J Radiat Biol | 2016 | https://conductscience.org/library/papers/27586010 | PubMed |
| 3 | 16932852 | REporting recommendations for tumor MARKer prognostic studies (REMARK). | Breast Cancer Res Treat | 2006 | https://conductscience.org/library/papers/16932852 | PubMed |
| 4 | 5687489 | Radiation reaction in ataxia telangiectasia. | Am J Dis Child | 1968 | https://conductscience.org/library/papers/5687489 | PubMed |
| 5 | 26844275 | Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial. | EBioMedicine | 2015 | https://conductscience.org/library/papers/26844275 | PubMed |
| 6 | 28497027 | Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era. | Front Oncol | 2017 | https://conductscience.org/library/papers/28497027 | PubMed |
| 7 | 27106550 | Correlation between DNA damage responses of skin to a test dose of radiation and late adverse effects of earlier breast radiotherapy. | Radiother Oncol | 2016 | https://conductscience.org/library/papers/27106550 | PubMed |
| 8 | 10524426 | Altered apoptotic profiles in irradiated patients with increased toxicity. | Int J Radiat Oncol Biol Phys | 1999 | https://conductscience.org/library/papers/10524426 | PubMed |
| 9 | 22178455 | Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. | Cancer Treat Rev | 2012 | https://conductscience.org/library/papers/22178455 | PubMed |
| 10 | 29228705 | YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways. | Oncotarget | 2017 | https://conductscience.org/library/papers/29228705 | PubMed |
| 11 | 27936985 | T lymphocytes to predict radiation-induced late effects in normal tissues. | Expert Rev Mol Diagn | 2017 | https://conductscience.org/library/papers/27936985 | PubMed |
| 12 | 28915682 | Systematic review and meta-analysis of the efficacy of breast conservation therapy followed by radiotherapy in four breast cancer subtypes. | Oncotarget | 2017 | https://conductscience.org/library/papers/28915682 | PubMed |
| 13 | 22385917 | Predictive factors for local recurrence in breast cancer. | Semin Radiat Oncol | 2012 | https://conductscience.org/library/papers/22385917 | PubMed |
| 14 | 22832933 | Validation of a radiosensitivity molecular signature in breast cancer. | Clin Cancer Res | 2012 | https://conductscience.org/library/papers/22832933 | PubMed |
| 15 | 25497158 | Late side-effects after curative intent radiotherapy: Identification of hypersensitive patients for personalized strategy. | Crit Rev Oncol Hematol | 2015 | https://conductscience.org/library/papers/25497158 | PubMed |
| 16 | 11823860 | Gene expression profiling predicts clinical outcome of breast cancer. | Nature | 2002 | https://conductscience.org/library/papers/11823860 | PubMed |
| 17 | 23580069 | The impact of breast cosmetic and functional outcomes on quality of life: long-term results from the St. George and Wollongong randomized breast boost trial. | Breast Cancer Res Treat | 2013 | https://conductscience.org/library/papers/23580069 | PubMed |
| 18 | 10799729 | Cellular radiosensitivity and complication risk after curative radiotherapy. | Radiother Oncol | 2000 | https://conductscience.org/library/papers/10799729 | PubMed |
| 19 | 23917950 | Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. | Ann Oncol | 2013 | https://conductscience.org/library/papers/23917950 | PubMed |
| 20 | 12829674 | Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. | J Clin Oncol | 2003 | https://conductscience.org/library/papers/12829674 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40910254 | BUB1B promotes homologous recombination‑mediated DNA damage repair in breast cancer cells through the PI3K/AKT signaling pathway. | Oncol Rep | 2025 | https://conductscience.org/library/papers/40910254 | PubMed |
| 35108162 | Effects of noncoding RNAs in radiotherapy response in breast cancer: a systematic review. | Cell Cycle | 2022 | https://conductscience.org/library/papers/35108162 | PubMed |
| 33149754 | Deciphering of Key Pharmacological Pathways of Poria Cocos Intervention in Breast Cancer Based on Integrated Pharmacological Method. | Evid Based Complement Alternat Med | 2020 | https://conductscience.org/library/papers/33149754 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29675397
GET https://conductscience.org/api/papers/v1/29675397/references?page=2